Cargando…

Role of surgery in T4N0-3M0 esophageal cancer

BACKGROUND: This study aimed to investigate an unsettled issue that whether T4 esophageal cancer could benefit from surgery. METHODS: Patients with T4N0-3M0 esophageal cancer from 2004 to 2015 from the Surveillance, Epidemiology, and End Results (SEER) database were included in this study. Kaplan–Me...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qi, Chen, Hu, Liwen, Zhang, Chi, Wang, Kang, Qiu, Bingmei, Yi, Jun, Shen, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10680323/ https://www.ncbi.nlm.nih.gov/pubmed/38008742 http://dx.doi.org/10.1186/s12957-023-03239-8

Ejemplares similares

Difference in failure patterns of pT3-4N0-3M0 esophageal cancer treated by surgery vs surgery plus radiotherapy
por: Zeng, Ya, et al.
Publicado: (2019)

Management of Clinical T1N0M0 Esophageal Cancer
por: Yang, Andrew J., et al.
Publicado: (2019)

Survival benefit of surgery with radiotherapy vs surgery alone to patients with T2-3N0M0 stage esophageal adenocarcinoma
por: Song, Yaqi, et al.
Publicado: (2016)

Risk factors for tumor recurrence in patients with pT(3)N(0)M(0) thoracic esophageal squamous cell carcinoma after esophagectomy
por: Feng, Wei, et al.
Publicado: (2020)

Postoperative survival effect of the number of examined lymph nodes on esophageal squamous cell carcinoma with pathological stage T1–3N0M0
por: Wu, Lei-Lei, et al.
Publicado: (2022)

Survival risk prediction model for patients with pT(1–3) N(0)M(0) esophageal squamous cell carcinoma after R0 esophagectomy with two-field lymphadenectomy for therapeutic purposes
por: Qi, Zhan, et al.
Publicado: (2021)

Nutritional and clinical outcomes of chemoradiotherapy for clinical T1N0M0 esophageal carcinoma
por: Sakanaka, Katsuyuki, et al.
Publicado: (2019)

Analysis of the causes of failure after radical surgery in patients with (P)T(3)N(0)M(0) thoracic esophageal squamous cell carcinoma and consideration of postoperative radiotherapy
por: Shen, Wen-Bin, et al.
Publicado: (2017)

Impact of duration of adjuvant chemotherapy in radically resected patients with T4bN1-3M0/TxN3bM0 gastric cancer
por: Wang, Qi-Wei, et al.
Publicado: (2018)

Patterns of failure and long-term outcome of postoperative radiotherapy on the survival of patients with pathological T3N0M0 esophageal cancer
por: Song, Chunyang, et al.
Publicado: (2022)

Induction therapy for clinical stage T2N0M0 esophageal cancer: A systematic review and meta-analysis
por: Lv, Hong-Wei, et al.
Publicado: (2018)

Prognostic nomogram and risk factors for predicting survival in patients with pT2N0M0 esophageal squamous carcinoma
por: Kang, Mei, et al.
Publicado: (2023)

Impact of postoperative radiotherapy for T3N0M0 esophageal cancer patients: A population‐based study
por: Ge, Yizhi, et al.
Publicado: (2020)

Radiotherapy for T1N0M0 Esophageal Cancer: Analyses of the Predictive Factors and the Role of Endoscopic Submucosal Dissection in the Local Control
por: Suzuki, Gen, et al.
Publicado: (2018)

Comparison of T2N0M0 and T3aN0M0 in Predicting the Prognosis of Patients With Renal Cell Carcinoma
por: He, Xiaobo, et al.
Publicado: (2020)

Establishment and validation of a prognostic risk classification for patients with stage T1-3N0M0 esophageal squamous cell carcinoma
por: Huang, Yang-Yu, et al.
Publicado: (2023)

Prognostic factors of T2aN0M0 (T3‐4cmN0M0, stage IB) non‐small‐cell lung cancer after surgery: Single‐center real‐world research
por: Liu, Lei, et al.
Publicado: (2021)

Unresected small lymph node assessment predicts prognosis for patients with pT3N0M0 thoracic esophageal squamous cell carcinoma
por: Wang, Yi, et al.
Publicado: (2021)

Evaluation of Adjuvant Treatments for T1 N0 M0 Triple-Negative Breast Cancer
por: Zhai, Zhen, et al.
Publicado: (2020)

Survival benefit of perioperative chemotherapy for T1–3N0M0 stage esophageal cancer: a SEER database analysis
por: Shao, Yue, et al.
Publicado: (2021)

Prognostic nomograms and risk-stratifying systems for predicting survival in patients with resected pT2-4aN0M0 esophageal carcinoma
por: Dou, Xiao-Meng, et al.
Publicado: (2021)

Patterns of Lymph Node Recurrence after Radical Surgery Impacting on Survival of Patients with pT1-3N0M0 Thoracic Esophageal Squamous Cell Carcinoma
por: Chen, Xiao-li, et al.
Publicado: (2014)

A Dilemma in Staging of Esophageal Cancer: How Should We Stage ypT0 N2 M0 Esophageal Cancer after Neoadjuvant Therapy?
por: Celik, Sebahattin, et al.
Publicado: (2015)

The critical impact of tumor size in predicting cancer special survival for T3aM0M0 renal cell carcinoma: A proposal of an alternative T3aN0M0 stage
por: Li, Luping, et al.
Publicado: (2020)

Efficacy, safety, and controversy of ultrasound-guided radiofrequency ablation in the treatment of T1N0M0 papillary thyroid carcinoma
por: Yi, Zhang, et al.
Publicado: (2022)

Indications for adjuvant chemotherapy in patients with AJCC stage IIa T3N0M0 and T1N2M0 gastric cancer—an east and west multicenter study
por: Huang, Ze-Ning, et al.
Publicado: (2019)

Comparison of Diagnosis of Esophageal Motility Disorders by Chicago Classification Versions 3.0 and 4.0
por: Noh, Jin Hee, et al.
Publicado: (2023)

Is Adjuvant Chemotherapy Beneficial to All Patients With pT3N0M0 Stage Gastric Cancer?
por: Huang, Jiao-Bao, et al.
Publicado: (2021)

Endoscopic therapy versus esophagectomy for T1bN0M0 esophageal cancer: A population-based study using propensity score matching
por: Zhu, Jiamin, et al.
Publicado: (2023)

Stereotactic body radiotherapy for T3 and T4N0M0 non–small cell lung cancer
por: Eriguchi, Takahisa, et al.
Publicado: (2016)

Prognostic factors in clinical T1N0M0 thoracic esophageal squamous cell carcinoma invading the muscularis mucosa or submucosa
por: Uchinami, Yusuke, et al.
Publicado: (2016)

The Prognostic Impact of Tumor Location in pT3N0M0 Upper Urinary Tract Urothelial Carcinoma: A Retrospective Cohort Study
por: Chen, Tzu Shuang, et al.
Publicado: (2022)

Association of survival with adjuvant radiotherapy for pN0 esophageal cancer
por: Gao, Huijiang, et al.
Publicado: (2023)

Solid component proportion is an important predictor of tumor invasiveness in clinical stage T(1)N(0)M(0) (cT(1)N(0)M(0)) lung adenocarcinoma
por: Li, Meng, et al.
Publicado: (2018)

Comparative study of esophagectomy, endoscopic therapy, and radiotherapy for cT1N0M0 esophageal cancer in elderly patients: A SEER database analysis
por: Qin, Jianjun, et al.
Publicado: (2019)

Prognostic impact of examined lymph node count in pT1N0M0 esophageal cancer: A population‐based study
por: Liu, Ying, et al.
Publicado: (2019)

Reconsidering N component of cancer staging for T1-2N0-2M0 small-cell lung cancer: a retrospective study based on multicenter cohort
por: Wu, Lei-Lei, et al.
Publicado: (2023)

The long-term impact of tumor burden in pT3N0M0 esophageal squamous cell carcinoma: A propensity score-matched analysis
por: Li, Tingting, et al.
Publicado: (2019)

Differentiating peripheral cholangiocarcinoma in stages T1N0M0 and T2N0M0 from hepatic hypovascular nodules using dynamic contrast-enhanced MRI
por: Li, Shihong, et al.
Publicado: (2017)

Optimal Surgery Type and Adjuvant Therapy for T1N0M0 Lung Large Cell Neuroendocrine Carcinoma
por: Peng, Kunwei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6ugkipeg4tdmco34m6vnt1uc59